Projects funded by the NCN

Noradrenergic modulation of cocaine-seeking

Call: SONATA 6 , Panel: NZ4

Principal investigator: dr Wojciech Solecki

Instytut Farmakologii PAN

seQinspector - genome-wide analysis of gene transcription regulation mechanisms

Call: PRELUDIUM 1 , Panel: NZ2

Principal investigator: dr Marcin Piechota

Instytut Farmakologii PAN

Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

Call: OPUS 2 , Panel: NZ4

Principal investigator: dr hab. Joanna Mika

Instytut Farmakologii PAN

The influence of molecular fingerprint bit density on chemical pattern recognition effectiveness

Call: PRELUDIUM 2 , Panel: NZ2

Principal investigator: Rafał Kurczab

Instytut Farmakologii PAN

Define the role and modulation of immune diabetes changed factors - their importance to the action of analgesics.

Call: PRELUDIUM 3 , Panel: NZ4

Principal investigator: Magdalena Żychowska

Instytut Farmakologii PAN

The role of glucocorticoids in the regulaton of neurodegenerative prosses

Call: PRELUDIUM 3 , Panel: NZ7

Principal investigator: Anna Kurek

Instytut Farmakologii PAN

The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat...

Call: OPUS 3 , Panel: NZ4

Principal investigator: dr Joanna Solich

Instytut Farmakologii PAN

Plasticity of glutamatergic synapses on dopamine neurons: the mechanism of habit formation.

Call: HARMONIA 3 , Panel: NZ4

Principal investigator: dr hab. Jan Rodriguez-Parkitna

Instytut Farmakologii PAN

The role of microRNA biogenesis system in vulnerability and resilience to stress in an animal model of depression

Call: PRELUDIUM 9 , Panel: NZ4

Principal investigator: Dariusz Żurawek

Instytut Farmakologii PAN

Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

Call: HARMONIA 7 , Panel: NZ7

Principal investigator: Sabina Podlewska

Instytut Farmakologii PAN

The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

Call: OPUS 5 , Panel: NZ7

Principal investigator: dr hab. Mariusz Papp

Instytut Farmakologii PAN

Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

Call: PRELUDIUM 5 , Panel: NZ7

Principal investigator: Katarzyna Kamińska

Instytut Farmakologii PAN

The influence of 5-HT7 and NMDA receptor ligands with possible antidepressive properties on the activity of rat dorsal r...

Call: OPUS 6 , Panel: NZ4

Principal investigator: prof. Grzegorz Hess

Instytut Farmakologii PAN

Evaluation of histopathological changes in the rats tissues after acute and chronic administration of the compounds from...

Call: PRELUDIUM 6 , Panel: NZ7

Principal investigator: Edyta Możdżeń

Instytut Farmakologii PAN

The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Jacek Wójcikowski

Instytut Farmakologii PAN

Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genet...

Call: OPUS 7 , Panel: NZ7

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii PAN

Molecular mechanism of action of antidepressant drugs in the in vitro model of contact allergy in the human cell line Ha...

Call: PRELUDIUM 7 , Panel: NZ6

Principal investigator: Katarzyna Curzytek

Instytut Farmakologii PAN

The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CY...

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: Agnieszka Basińska-Ziobroń

Instytut Farmakologii PAN

Molecular mechanism of unique action of clozapine in the context of GPCR.

Call: OPUS 8 , Panel: NZ7

Principal investigator: dr Agata Faron-Górecka

Instytut Farmakologii PAN